TreeWAS – Variant ID: rs12635820

Hospitalization Episode Statistics (HES)

Self-Reported Statistics (SRS)

Hierarchical visualisation How to interpret this figure?

Click here to show this figure without filtering.

Click on a node to zoom (except terminal nodes).

Download this figure in format

Results table

Term	Risk posterior probability	No effect posterior probability	Protective posterior probability
D35.1 Parathyroid gland	0.000	0.976	0.024
D35 Benign neoplasm of other and unspecified endocrine glands	0.000	0.983	0.017
I24.8 Other forms of acute ischaemic heart disease	0.017	0.983	0.000
I24.1 Dressler's syndrome	0.017	0.983	0.000
D35.2 Pituitary gland	0.000	0.984	0.016
I24 Other acute ischaemic heart diseases	0.016	0.984	0.000
I24.0 Coronary thrombosis not resulting in myocardial infarction	0.016	0.984	0.000
M23.49 Loose body in knee-Unspec lig/men	0.000	0.984	0.016
E66.9 Obesity, unspecified	0.000	0.986	0.014
D35.0 Adrenal gland	0.000	0.987	0.013
D35.9 Endocrine gland, unspecified	0.000	0.987	0.012
D35.8 Pluriglandular involvement	0.000	0.987	0.012
D35.7 Other specified endocrine glands	0.000	0.987	0.012
D35.6 Aortic body and other paraganglia	0.000	0.987	0.012
D35.5 Carotid body	0.000	0.987	0.012
D35.4 Pineal gland	0.000	0.987	0.012
D35.3 Craniopharyngeal duct	0.000	0.987	0.012
C82.9 Follicular non-Hodgkin's lymphoma, unspecified	0.010	0.990	0.000
S42.20 Fracture of upper end of humerus (closed)	0.000	0.990	0.010
K74.6 Other and unspecified cirrhosis of liver	0.000	0.992	0.008
I24.9 Acute ischaemic heart disease, unspecified	0.008	0.992	0.000
G40.2 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with complex partial seizures	0.008	0.992	0.000
M23.4 Loose body in knee	0.000	0.992	0.008
K74.0 Hepatic fibrosis	0.000	0.992	0.008
D11.0 Parotid gland	0.008	0.992	0.000
K74 Fibrosis and cirrhosis of liver	0.000	0.993	0.007
M23.43 Loose body in knee-Med lig/oth men	0.000	0.993	0.007
C45.0 Mesothelioma of pleura	0.007	0.993	0.000
R59.1 Generalised enlarged lymph nodes	0.007	0.993	0.000
C82 Follicular [nodular] non-Hodgkin's lymphoma	0.006	0.994	0.000
G43.9 Migraine, unspecified	0.006	0.994	0.000
C82.3 Follicular lymphoma grade IIIa	0.006	0.994	0.000
M23.47 Loose body in knee-Capsular lig	0.000	0.994	0.006
M23.46 Loose body in knee-O/unsp lat men	0.000	0.994	0.006
M23.45 Loose body in knee-Pst hrn lat men	0.000	0.994	0.006
M23.44 Loose body in knee-Lat lig/ant men	0.000	0.994	0.006
M23.42 Loose body in knee-Pst lig/hrn men	0.000	0.994	0.006
M23.41 Loose body in knee-Ant lig/hrn men	0.000	0.994	0.006
G40 Epilepsy	0.006	0.994	0.000
H01.0 Blepharitis	0.000	0.994	0.006
S81.8 Open wound of other parts of lower leg	0.000	0.994	0.006
Z22.3 Carrier of other specified bacterial diseases	0.000	0.994	0.006
S62.00 Fracture of navicular [scaphoid] bone of hand (closed)	0.006	0.994	0.000
K74.4 Secondary biliary cirrhosis	0.000	0.994	0.005
K74.2 Hepatic fibrosis with hepatic sclerosis	0.000	0.994	0.005
K74.1 Hepatic sclerosis	0.000	0.994	0.005
M23.40 Loose body in knee-Mult sites	0.000	0.994	0.005
G40.7 Petit mal, unspecified, without grand mal seizures	0.006	0.994	0.000
N48.4 Impotence of organic origin	0.006	0.994	0.000
K76 Other diseases of liver	0.000	0.995	0.005
F81.9 Developmental disorder of scholastic skills, unspecified	0.000	0.995	0.005
G40.1 Localisation-related (focal) (partial) symptomatic epilepsy and epileptic syndromes with simple partial seizures	0.005	0.995	0.000
K76.9 Liver disease, unspecified	0.000	0.995	0.005
K74.5 Biliary cirrhosis, unspecified	0.000	0.995	0.005
K76.7 Hepatorenal syndrome	0.000	0.995	0.005
G40.0 Localisation-related (focal) (partial) idiopathic epilepsy and epileptic syndromes with seizures of localised onset	0.005	0.995	0.000
N18.4 Chronic kidney disease, stage 4	0.000	0.995	0.005
G40.3 Generalised idiopathic epilepsy and epileptic syndromes	0.005	0.995	0.000
G40.5 Special epileptic syndromes	0.005	0.995	0.000
K76.0 Fatty (change of) liver, not elsewhere classified	0.000	0.995	0.005
C82.1 Mixed small cleaved and large cell, follicular	0.005	0.995	0.000
S42.2 Fracture of upper end of humerus	0.000	0.995	0.005
C82.6 Cutaneous follicle centre lymphoma	0.005	0.995	0.000
C82.5 Diffuse follicle centre lymphoma	0.005	0.995	0.000
C82.4 Follicular lymphoma grade IIIb	0.005	0.995	0.000
K74.3 Primary biliary cirrhosis	0.000	0.995	0.005
C82.7 Other types of follicular non-Hodgkin's lymphoma	0.005	0.995	0.000
K70-K77 Diseases of liver	0.000	0.995	0.005
Q61.3 Polycystic kidney, unspecified	0.000	0.995	0.005
G40.4 Other generalised epilepsy and epileptic syndromes	0.005	0.995	0.000
C48.2 Peritoneum, unspecified	0.005	0.995	0.000
C82.2 Large cell, follicular	0.004	0.995	0.000
K61.3 Ischiorectal abscess	0.000	0.995	0.005
K72 Hepatic failure, not elsewhere classified	0.000	0.995	0.005
K72.9 Hepatic failure, unspecified	0.000	0.995	0.005
K73.9 Chronic hepatitis, unspecified	0.000	0.995	0.005
O90.8 Other complications of the puerperium, not elsewhere classified	0.000	0.995	0.005
K73 Chronic hepatitis, not elsewhere classified	0.000	0.995	0.005
Q61 Cystic kidney disease	0.000	0.995	0.005
C45 Mesothelioma	0.004	0.996	0.000
Q61.2 Polycystic kidney, adult type	0.000	0.996	0.004
Q61.9 Cystic kidney disease, unspecified	0.000	0.996	0.004
C82.0 Small cleaved cell, follicular	0.004	0.996	0.000
K76.5 Hepatic veno-occlusive disease	0.000	0.996	0.004
K76.4 Peliosis hepatis	0.000	0.996	0.004
K76.3 Infarction of liver	0.000	0.996	0.004
K76.2 Central haemorrhagic necrosis of liver	0.000	0.996	0.004
K76.1 Chronic passive congestion of liver	0.000	0.996	0.004
G40.6 Grand mal seizures, unspecified (with or without petit mal)	0.004	0.996	0.000
R72 Abnormality of white blood cells, not elsewhere classified	0.004	0.996	0.000
K76.8 Other specified diseases of liver	0.000	0.996	0.004
M21.16 Varus deformity, not elsewhere classified (Lower leg)	0.000	0.996	0.004
K72.0 Acute and subacute hepatic failure	0.000	0.996	0.004
C45.9 Mesothelioma, unspecified	0.004	0.996	0.000
Q61.5 Medullary cystic kidney	0.000	0.996	0.004
C48 Malignant neoplasm of retroperitoneum and peritoneum	0.004	0.996	0.000
S42.21 Fracture of upper end of humerus (open)	0.000	0.996	0.004
H04.3 Acute and unspecified inflammation of lachrymal passages	0.000	0.996	0.004
K73.2 Chronic active hepatitis, not elsewhere classified	0.000	0.996	0.004
N39.3 Stress incontinence	0.000	0.996	0.004
C83.8 Other types of diffuse non-Hodgkin's lymphoma	0.004	0.996	0.000
K77 Liver disorders in diseases classified elsewhere	0.000	0.996	0.004
H01 Other inflammation of eyelid	0.000	0.996	0.004
D22.3 Melanocytic naevi of other and unspecified parts of face	0.004	0.996	0.000
K73.1 Chronic lobular hepatitis, not elsewhere classified	0.000	0.996	0.003
K73.0 Chronic persistent hepatitis, not elsewhere classified	0.000	0.996	0.003
F81 Specific developmental disorders of scholastic skills	0.000	0.996	0.003
C48.0 Retroperitoneum	0.003	0.996	0.000
J04.0 Acute laryngitis	0.000	0.996	0.003
Q61.8 Other cystic kidney diseases	0.000	0.996	0.003
Q61.4 Renal dysplasia	0.000	0.996	0.003
Q61.1 Polycystic kidney, infantile type	0.000	0.996	0.003
C45.2 Mesothelioma of pericardium	0.003	0.997	0.000
C45.1 Mesothelioma of peritoneum	0.003	0.997	0.000
G43 Migraine	0.003	0.997	0.000
Q61.0 Congenital single renal cyst	0.000	0.997	0.003
S05.8 Other injuries of eye and orbit	0.003	0.997	0.000
H01.9 Inflammation of eyelid, unspecified	0.000	0.997	0.003
G24.9 Dystonia, unspecified	0.003	0.997	0.000
Y45.0 Opioids and related analgesics	0.003	0.997	0.000
Z43.6 Attention to other artificial openings of urinary tract	0.003	0.997	0.000
S68.1 Traumatic amputation of other single finger (complete)(partial)	0.000	0.997	0.003
H04.2 Epiphora	0.000	0.997	0.003
C83 Diffuse non-Hodgkin's lymphoma	0.003	0.997	0.000
D11 Benign neoplasm of major salivary glands	0.003	0.997	0.000
Y45.1 Salicylates	0.003	0.997	0.000
E66 Obesity	0.000	0.997	0.003
K71 Toxic liver disease	0.000	0.997	0.003
Y45 Analgesics, antipyretics and anti-inflammatory drugs	0.003	0.997	0.000
H04.5 Stenosis and insufficiency of lachrymal passages	0.000	0.997	0.003
K76.6 Portal hypertension	0.000	0.997	0.003
M21.26 Flexion deformity (Lower leg)	0.000	0.997	0.003
K72.1 Chronic hepatic failure	0.000	0.997	0.003
K73.8 Other chronic hepatitis, not elsewhere classified	0.000	0.997	0.003
G40.9 Epilepsy, unspecified	0.003	0.997	0.000
H04 Disorders of lachrymal system	0.000	0.997	0.003
C83.3 Large cell (diffuse)	0.003	0.997	0.000
M24.16 Other articular cartilage disorders (Lower leg)	0.000	0.997	0.003
C48.8 Overlapping lesion of retroperitoneum and peritoneum	0.003	0.997	0.000
Y45.5 4-Aminophenol derivatives	0.003	0.997	0.000
G43.8 Other migraine	0.003	0.997	0.000
H01.1 Non-infectious dermatoses of eyelid	0.000	0.997	0.003
C83.7 Burkitt's tumour	0.003	0.997	0.000
C45.7 Mesothelioma of other sites	0.003	0.997	0.000
C83.9 Diffuse non-Hodgkin's lymphoma, unspecified	0.003	0.997	0.000
G43.3 Complicated migraine	0.003	0.997	0.000
K77.8 Liver disorders in other diseases classified elsewhere	0.000	0.997	0.003
K77.0 Liver disorders in infectious and parasitic diseases classified elsewhere	0.000	0.997	0.003
C48.1 Specified parts of peritoneum	0.003	0.997	0.000
F81.8 Other developmental disorders of scholastic skills	0.000	0.997	0.003
F81.3 Mixed disorder of scholastic skills	0.000	0.997	0.003
F81.2 Specific disorder of arithmetical skills	0.000	0.997	0.003
F81.1 Specific spelling disorder	0.000	0.997	0.003
F81.0 Specific reading disorder	0.000	0.997	0.003
C45-C49 Malignant neoplasms of mesothelial and soft tissue	0.003	0.997	0.000
G43.2 Status migrainosus	0.003	0.997	0.000
D11.9 Major salivary gland, unspecified	0.003	0.997	0.000
Y45.8 Other analgesics and antipyretics	0.003	0.997	0.000
E66.2 Extreme obesity with alveolar hypoventilation	0.000	0.997	0.003
L30.9 Dermatitis, unspecified	0.003	0.997	0.000
Y83.3 Surgical operation with formation of external stoma	0.003	0.997	0.000
G43.0 Migraine without aura [common migraine]	0.003	0.997	0.000
C83.6 Undifferentiated (diffuse)	0.003	0.997	0.000
C83.5 Lymphoblastic (diffuse)	0.003	0.997	0.000
C83.4 Immunoblastic (diffuse)	0.003	0.997	0.000
C83.2 Mixed small and large cell (diffuse)	0.003	0.997	0.000
S62.0 Fracture of navicular [scaphoid] bone of hand	0.003	0.997	0.000
E66.1 Drug-induced obesity	0.000	0.997	0.002
G40.8 Other epilepsy	0.002	0.997	0.000
Y45.9 Analgesic, antipyretic and anti-inflammatory drug, unspecified	0.003	0.997	0.000
K71.9 Toxic liver disease, unspecified	0.000	0.997	0.002
K71.8 Toxic liver disease with other disorders of liver	0.000	0.997	0.002
K71.7 Toxic liver disease with fibrosis and cirrhosis of liver	0.000	0.997	0.002
K71.5 Toxic liver disease with chronic active hepatitis	0.000	0.997	0.002
K71.4 Toxic liver disease with chronic lobular hepatitis	0.000	0.997	0.002
K71.3 Toxic liver disease with chronic persistent hepatitis	0.000	0.997	0.002
K71.2 Toxic liver disease with acute hepatitis	0.000	0.997	0.002
K71.0 Toxic liver disease with cholestasis	0.000	0.997	0.002
Y45.4 Antirheumatics	0.002	0.997	0.000
M80.10 Postoophorectomy osteoporosis with pathological fracture (Multiple sites)	0.003	0.997	0.000
Y45.2 Propionic acid derivatives	0.003	0.997	0.000
H04.8 Other disorders of lachrymal system	0.000	0.997	0.003
Z22 Carrier of infectious disease	0.000	0.997	0.003
D11.7 Other major salivary glands	0.002	0.997	0.000
H04.0 Dacryoadenitis	0.000	0.997	0.002
K71.6 Toxic liver disease with hepatitis, not elsewhere classified	0.000	0.998	0.002
M21.1 Varus deformity, not elsewhere classified	0.000	0.998	0.002
C83.1 Small cleaved cell (diffuse)	0.002	0.998	0.000
C83.0 Small cell (diffuse)	0.002	0.998	0.000
H04.6 Other changes in lachrymal passages	0.000	0.998	0.002
K71.1 Toxic liver disease with hepatic necrosis	0.000	0.998	0.002
H01.8 Other specified inflammation of eyelid	0.000	0.998	0.002
N03.9 Unspecified	0.000	0.998	0.002
Y43.1 Antineoplastic antimetabolites	0.002	0.998	0.000
H04.9 Disorder of lachrymal system, unspecified	0.000	0.998	0.002
Z43.1 Attention to gastrostomy	0.002	0.998	0.000
Z40.0 Prophylactic surgery for risk-factors related to malignant neoplasms	0.000	0.998	0.002
C47 Malignant neoplasm of peripheral nerves and autonomic nervous system	0.002	0.998	0.000
C46 Kaposi's sarcoma	0.002	0.998	0.000
T14.0 Superficial injury of unspecified body region	0.000	0.998	0.002
M53.38 Sacrococcygeal disorders, not elsewhere classified-Sacral/s	0.000	0.998	0.002
M21.2 Flexion deformity	0.000	0.998	0.002
Y40.1 Cefalosporins and other -lactam antibiotics	0.002	0.998	0.000
S05.1 Contusion of eyeball and orbital tissues	0.002	0.998	0.000
Y43.4 Immunosuppressive agents	0.002	0.998	0.000
S05 Injury of eye and orbit	0.002	0.998	0.000
S62.01 Fracture of navicular [scaphoid] bone of hand (open)	0.002	0.998	0.000
D25.2 Subserosal leiomyoma of uterus	0.002	0.998	0.000
G44.0 Cluster headache syndrome	0.002	0.998	0.000
Y42.0 Glucocorticoids and synthetic analogs	0.002	0.998	0.000
F80-F89 Disorders of psychological development	0.000	0.998	0.002
Y42.7 Androgens and anabolic congeners	0.002	0.998	0.000
M25.37 Other instability of joint (Ankle and foot)	0.000	0.998	0.002
F80.1 Expressive language disorder	0.000	0.998	0.002
V49.4 Driver injured in collision with other and unspecified motor vehicles in traffic accident	0.000	0.998	0.002
Z22.9 Carrier of infectious disease, unspecified	0.000	0.998	0.002
Z22.6 Carrier of human T-lymphotropic virus type 1 [HTLV-1] infection	0.000	0.998	0.002
Z22.4 Carrier of infections with a predominantly sexual mode of transmission	0.000	0.998	0.002
Z22.2 Carrier of diphtheria	0.000	0.998	0.002
Z22.0 Carrier of typhoid	0.000	0.998	0.002
F80 Specific developmental disorders of speech and language	0.000	0.998	0.002
Y40-Y59 Drugs, medicaments and biological substances causing adverse effects in therapeutic use	0.002	0.998	0.000
M05.90 Seropositive rheumatoid arthritis, unspecified (Multiple sites)	0.002	0.998	0.000
H04.4 Chronic inflammation of lachrymal passages	0.000	0.998	0.002
R59.9 Enlarged lymph nodes, unspecified	0.002	0.998	0.000
Z22.5 Carrier of viral hepatitis	0.000	0.998	0.002
D03.7 Melanoma in situ of lower limb, including hip	0.000	0.998	0.002
Y41.0 Sulphonamides	0.002	0.998	0.000
Y48 Anaesthetics and therapeutic gases	0.002	0.998	0.000
Y41 Other systemic anti-infectives and antiparasitics	0.002	0.998	0.000
M21.19 Varus deformity, not elsewhere classified (Site unspecified)	0.000	0.998	0.002
M21.18 Varus deformity, not elsewhere classified (Other)	0.000	0.998	0.002
M21.15 Varus deformity, not elsewhere classified (Pelvic region and thigh)	0.000	0.998	0.002
M21.14 Varus deformity, not elsewhere classified (Hand)	0.000	0.998	0.002
M21.13 Varus deformity, not elsewhere classified (Forearm)	0.000	0.998	0.002
M21.12 Varus deformity, not elsewhere classified (Upper arm)	0.000	0.998	0.002
M21.11 Varus deformity, not elsewhere classified (Shoulder region)	0.000	0.998	0.002
M21.10 Varus deformity, not elsewhere classified (Multiple sites)	0.000	0.998	0.002
L30.8 Other specified dermatitis	0.002	0.998	0.000
S05.9 Injury of eye and orbit, part unspecified	0.002	0.998	0.000
Y42.6 Antigonadotrophins, antioestrogens, antiandrogens, not elsewhere classified	0.002	0.998	0.000
S05.6 Penetrating wound of eyeball without foreign body	0.002	0.998	0.000
M24.26 Disorder of ligament (Lower leg)	0.000	0.998	0.002
Z22.8 Carrier of other infectious diseases	0.000	0.998	0.002
S05.5 Penetrating wound of eyeball with foreign body	0.002	0.998	0.000
R59 Enlarged lymph nodes	0.002	0.998	0.000
Y42 Hormones and their synthetic substitutes and antagonists, not elsewhere classified	0.002	0.998	0.000
G40-G47 Episodic and paroxysmal disorders	0.002	0.998	0.000
E66.0 Obesity due to excess calories	0.000	0.998	0.002
Z22.1 Carrier of other intestinal infectious diseases	0.000	0.998	0.002
C81-C96 Malignant neoplasms, stated or presumed to be primary, of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
G24 Dystonia	0.002	0.998	0.000
M21.25 Flexion deformity (Pelvic region and thigh)	0.000	0.998	0.002
E83.5 Disorders of calcium metabolism	0.002	0.998	0.000
J92.9 Pleural plaque without asbestos	0.002	0.998	0.000
Y48.4 Anaesthetic, unspecified	0.002	0.998	0.000
Y43 Primarily systemic agents	0.002	0.998	0.000
M79.62 Pain in limb (Upper arm)	0.002	0.998	0.000
C46.9 Kaposi's sarcoma, unspecified	0.002	0.998	0.000
C46.8 Kaposi's sarcoma of multiple organs	0.002	0.998	0.000
C46.7 Kaposi's sarcoma of other sites	0.002	0.998	0.000
C46.3 Kaposi's sarcoma of lymph nodes	0.002	0.998	0.000
C46.2 Kaposi's sarcoma of palate	0.002	0.998	0.000
C46.1 Kaposi's sarcoma of soft tissue	0.002	0.998	0.000
C46.0 Kaposi's sarcoma of skin	0.002	0.998	0.000
C47.9 Peripheral nerves and autonomic nervous system, unspecified	0.002	0.998	0.000
C47.8 Overlapping lesion of peripheral nerves and autonomic nervous system	0.002	0.998	0.000
C47.6 Peripheral nerves of trunk, unspecified	0.002	0.998	0.000
C47.5 Peripheral nerves of pelvis	0.002	0.998	0.000
C47.4 Peripheral nerves of abdomen	0.002	0.998	0.000
C47.3 Peripheral nerves of thorax	0.002	0.998	0.000
C47.2 Peripheral nerves of lower limb, including hip	0.002	0.998	0.000
C47.1 Peripheral nerves of upper limb, including shoulder	0.002	0.998	0.000
C47.0 Peripheral nerves of head, face and neck	0.002	0.998	0.000
F84 Pervasive developmental disorders	0.000	0.998	0.002
G93.2 Benign intracranial hypertension	0.002	0.998	0.000
Y40 Systemic antibiotics	0.002	0.998	0.000
M21.17 Varus deformity, not elsewhere classified (Ankle and foot)	0.000	0.998	0.002
M21.27 Flexion deformity (Ankle and foot)	0.000	0.998	0.002
E83.3 Disorders of phosphorus metabolism	0.002	0.998	0.000
L30 Other dermatitis	0.002	0.998	0.000
M21.29 Flexion deformity (Site unspecified)	0.000	0.998	0.002
M21.28 Flexion deformity (Other)	0.000	0.998	0.002
M21.23 Flexion deformity (Forearm)	0.000	0.998	0.002
M21.22 Flexion deformity (Upper arm)	0.000	0.998	0.002
M21.21 Flexion deformity (Shoulder region)	0.000	0.998	0.002
M21.20 Flexion deformity (Multiple sites)	0.000	0.998	0.002
Q60-Q64 Congenital malformations of the urinary system	0.000	0.998	0.002
S05.7 Avulsion of eye	0.002	0.998	0.000
S05.4 Penetrating wound of orbit with or without foreign body	0.002	0.998	0.000
S42.00 Fracture of clavicle (closed)	0.000	0.998	0.002
V78.1 Passenger injured in nontraffic accident	0.002	0.998	0.000
Y58 Bacterial vaccines	0.002	0.998	0.000
Y40.7 Antifungal antibiotics, systemically used	0.002	0.998	0.000
Y48.3 Local anaesthetics	0.002	0.998	0.000
F89 Unspecified disorder of psychological development	0.000	0.998	0.002
F88 Other disorders of psychological development	0.000	0.998	0.002
F83 Mixed specific developmental disorders	0.000	0.998	0.002
F82 Specific developmental disorder of motor function	0.000	0.998	0.002
G24.0 Drug-induced dystonia	0.002	0.998	0.000
M54.46 Lumbago with sciatica (Lumbar region)	0.000	0.998	0.002
Y45.3 Other nonsteroidal anti-inflammatory drugs [NSAID]	0.002	0.998	0.000
Y56 Topical agents primarily affecting skin and mucous membrane and ophthalmological, otorhinolaryngological and dental drugs	0.002	0.998	0.000
Y47 Sedatives, hypnotics and antianxiety drugs	0.002	0.998	0.000
F80.9 Developmental disorder of speech and language, unspecified	0.000	0.998	0.002
F80.8 Other developmental disorders of speech and language	0.000	0.998	0.002
F80.3 Acquired aphasia with epilepsy [Landau-Kleffner]	0.000	0.998	0.002
F80.2 Receptive language disorder	0.000	0.998	0.002
F80.0 Specific speech articulation disorder	0.000	0.998	0.002
R85.5 Abnormal microbiological findings	0.000	0.998	0.002
S05.2 Ocular laceration and rupture with prolapse or loss of intraocular tissue	0.002	0.998	0.000
Y41.5 Antiviral drugs	0.002	0.998	0.000
Y44.3 Anticoagulant antagonists, vitamin K and other coagulants	0.002	0.998	0.000
Q64 Other congenital malformations of urinary system	0.000	0.998	0.002
G44 Other headache syndromes	0.002	0.998	0.000
Y50 Central nervous system stimulants, not elsewhere classified	0.002	0.998	0.000
F84.5 Asperger's syndrome	0.000	0.998	0.002
Y40.3 Macrolides	0.002	0.998	0.000
Y48.5 Therapeutic gases	0.002	0.998	0.000
Y48.2 Other and unspecified general anaesthetics	0.002	0.998	0.000
Y48.1 Parenteral anaesthetics	0.002	0.998	0.000
Y48.0 Inhaled anaesthetics	0.002	0.998	0.000
C86 Other specified types of T/NK-cell lymphoma	0.002	0.998	0.000
Y53 Agents primarily affecting the gastro-intestinal system	0.002	0.998	0.000
Y44 Agents primarily affecting blood constituents	0.002	0.998	0.000
N48.5 Ulcer of penis	0.002	0.998	0.000
Y40.4 Tetracyclines	0.002	0.998	0.000
Y41.9 Systemic anti-infective and antiparasitic, unspecified	0.002	0.998	0.000
Y41.4 Anthelminthics	0.002	0.998	0.000
Y41.3 Other antiprotozoal drugs	0.002	0.998	0.000
Y41.2 Antimalarials and drugs acting on other blood protozoa	0.002	0.998	0.000
Z91.1 Personal history of noncompliance with medical treatment and regimen	0.002	0.998	0.000
J20.9 Acute bronchitis, unspecified	0.002	0.998	0.000
J95.8 Other postprocedural respiratory disorders	0.002	0.998	0.000
Q64.3 Other atresia and stenosis of urethra and bladder neck	0.000	0.998	0.002
T83.5 Infection and inflammatory reaction due to prosthetic device, implant and graft in urinary system	0.000	0.998	0.002
U80.1 Methicillin resistant agent	0.000	0.998	0.002
C95 Leukaemia of unspecified cell type	0.002	0.998	0.000
Y55 Agents primarily acting on smooth and skeletal muscles and the respiratory system	0.002	0.998	0.000
N48.2 Other inflammatory disorders of penis	0.002	0.998	0.000
S05.3 Ocular laceration without prolapse or loss of intraocular tissue	0.002	0.998	0.000
X41.9 Unspecified place	0.002	0.998	0.000
M05.99 Seropositive rheumatoid arthritis, unspecified (Site unspecified)	0.002	0.998	0.000
M21.24 Flexion deformity (Hand)	0.000	0.998	0.002
Y40.8 Other systemic antibiotics	0.002	0.998	0.000
Y41.8 Other specified systemic anti-infectives and antiparasitics	0.002	0.998	0.000
Y42.9 Other and unspecified hormone antagonists	0.002	0.998	0.000
Y42.4 Oral contraceptives	0.002	0.998	0.000
Y42.1 Thyroid hormones and substitutes	0.002	0.998	0.000
Y58.0 BCG vaccine	0.002	0.998	0.000
Z94.8 Other transplanted organ and tissue status	0.002	0.998	0.000
C96 Other and unspecified malignant neoplasms of lymphoid, haematopoietic and related tissue	0.002	0.998	0.000
C94 Other leukaemias of specified cell type	0.002	0.998	0.000
M21.37 Wrist or foot drop (acquired) (Ankle and foot)	0.000	0.998	0.002
G24.4 Idiopathic orofacial dystonia	0.002	0.998	0.000
G24.2 Idiopathic nonfamilial dystonia	0.002	0.998	0.000
G24.1 Idiopathic familial dystonia	0.002	0.998	0.000
Y41.1 Antimycobacterial drugs	0.002	0.998	0.000
Y43.9 Primarily systemic agent, unspecified	0.002	0.998	0.000
Y43.8 Other primarily systemic agents, not elsewhere classified	0.002	0.998	0.000
Y43.6 Enzymes, not elsewhere classified	0.002	0.998	0.000
Y43.5 Acidifying and alkalising agents	0.002	0.998	0.000
Y43.2 Antineoplastic natural products	0.002	0.998	0.000
Y49.0 Tricyclic and tetracyclic antidepressants	0.002	0.998	0.000
N48 Other disorders of penis	0.002	0.998	0.000
F84.9 Pervasive developmental disorder, unspecified	0.000	0.998	0.001
F84.8 Other pervasive developmental disorders	0.000	0.998	0.001
F84.4 Overactive disorder associated with mental retardation and stereotyped movements	0.000	0.998	0.001
F84.3 Other childhood disintegrative disorder	0.000	0.998	0.001
F84.2 Rett's syndrome	0.000	0.998	0.001
F84.1 Atypical autism	0.000	0.998	0.001
F84.0 Childhood autism	0.000	0.998	0.001
S42.0 Fracture of clavicle	0.000	0.998	0.002
V78.6 Passenger injured in traffic accident	0.002	0.998	0.000
Y44.4 Antithrombotic drugs [platelet-aggregation inhibitors]	0.002	0.998	0.000
Y56.0 Local antifungal, anti-infective and anti-inflammatory drugs, not elsewhere classified	0.002	0.998	0.000
Y59 Other and unspecified vaccines and biological substances	0.002	0.998	0.000
Y49 Psychotropic drugs, not elsewhere classified	0.002	0.998	0.000
S06.60 Traumatic subarachnoid haemorrhage (without open intracranial wound)	0.000	0.998	0.002
M20.3 Other deformity of hallux (acquired)	0.000	0.998	0.002
Y40.2 Chloramphenicol group	0.002	0.998	0.000
C93 Monocytic leukaemia	0.002	0.998	0.000
V78 Bus occupant injured in noncollision transport accident	0.002	0.998	0.000
H04.1 Other disorders of lachrymal gland	0.000	0.998	0.002
L27.0 Generalised skin eruption due to drugs and medicaments	0.002	0.998	0.000
L30.5 Pityriasis alba	0.001	0.998	0.000
L30.2 Cutaneous autosensitisation	0.001	0.998	0.000
L30.1 Dyshidrosis [pompholyx]	0.001	0.998	0.000
L30.0 Nummular dermatitis	0.001	0.998	0.000
Y40.5 Aminoglycosides	0.002	0.998	0.000
C90 Multiple myeloma and malignant plasma cell neoplasms	0.002	0.998	0.000
M80.1 Postoophorectomy osteoporosis with pathological fracture	0.002	0.998	0.000
C86.5 Angioimmunoblastic T-cell lymphoma	0.001	0.998	0.000
Y53.8 Other agents primarily affecting the gastro-intestinal system	0.001	0.998	0.000
Y58.9 Other and unspecified bacterial vaccines	0.001	0.998	0.000
Y58.8 Mixed bacterial vaccines, except combinations with a pertussis component	0.001	0.998	0.000
Y58.6 Pertussis vaccine, including combinations with a pertussis component	0.001	0.998	0.000
Y58.5 Diphtheria vaccine	0.001	0.998	0.000
Y58.4 Tetanus vaccine	0.001	0.998	0.000
Y58.3 Plague vaccine	0.001	0.998	0.000
Y58.2 Cholera vaccine	0.001	0.998	0.000
Y58.1 Typhoid and paratyphoid vaccine	0.001	0.998	0.000
R85.7 Abnormal histological findings	0.000	0.998	0.002
Y44.0 Iron preparations and other anti-hypochromic-anaemia preparations	0.001	0.998	0.000
Y46.2 Hydantoin derivatives	0.001	0.998	0.000
Y47.1 Benzodiazepines	0.001	0.998	0.000
Q60 Renal agenesis and other reduction defects of kidney	0.000	0.998	0.002
G44.4 Drug-induced headache, not elsewhere classified	0.001	0.998	0.000
N48.1 Balanoposthitis	0.002	0.998	0.000
Y40.6 Rifamycins	0.001	0.998	0.000
Y47.9 Sedative, hypnotic and antianxiety drug, unspecified	0.001	0.998	0.000
Y47.8 Other sedatives, hypnotics and antianxiety drugs	0.001	0.998	0.000
Y47.5 Mixed sedatives and hypnotics, not elsewhere classified	0.001	0.998	0.000
Y47.4 Bromine compounds	0.001	0.998	0.000
Y47.3 Paraldehyde	0.001	0.998	0.000
Y47.2 Chloral derivatives	0.001	0.998	0.000
Y47.0 Barbiturates, not elsewhere classified	0.001	0.998	0.000
Y56.9 Topical agent, unspecified	0.001	0.998	0.000
Y56.8 Other topical agents	0.001	0.998	0.000
Y56.7 Dental drugs, topically applied	0.001	0.998	0.000
Y56.6 Otorhinolaryngological drugs and preparations	0.001	0.998	0.000
Y56.5 Ophthalmological drugs and preparations	0.001	0.998	0.000
Y56.4 Keratolytics, keratoplastics and other hair treatment drugs and preparations	0.001	0.998	0.000
Y56.2 Local astringents and local detergents	0.001	0.998	0.000
Y56.1 Antipruritics	0.001	0.998	0.000
Y90.8 Blood alcohol level of 240 mg/100 ml or more	0.001	0.998	0.000
Z43 Attention to artificial openings	0.002	0.998	0.000
G24.8 Other dystonia	0.001	0.998	0.000
G44.3 Chronic posttraumatic headache	0.001	0.998	0.000
L30.4 Erythema intertrigo	0.001	0.998	0.000
M21.3 Wrist or foot drop (acquired)	0.000	0.998	0.001
Q64.9 Congenital malformation of urinary system, unspecified	0.000	0.998	0.001
Q64.8 Other specified congenital malformations of urinary system	0.000	0.998	0.001
Q64.7 Other congenital malformations of bladder and urethra	0.000	0.998	0.001
Q64.6 Congenital diverticulum of bladder	0.000	0.998	0.001
Q64.5 Congenital absence of bladder and urethra	0.000	0.998	0.001
Q64.4 Malformation of urachus	0.000	0.998	0.001
Q64.2 Congenital posterior urethral valves	0.000	0.998	0.001
Q64.1 Exstrophy of urinary bladder	0.000	0.998	0.001
Q64.0 Epispadias	0.000	0.998	0.001
R85.8 Other abnormal findings	0.000	0.998	0.001
Y42.2 Antithyroid drugs	0.001	0.998	0.000
C88 Malignant immunoproliferative diseases	0.001	0.998	0.000
Y46 Antiepileptics and anti-Parkinsonism drugs	0.001	0.998	0.000
C86.6 Primary cutaneous CD30-positive T-cell proliferations	0.001	0.998	0.000
C86.4 Blastic NK-cell lymphoma	0.001	0.998	0.000
C86.3 Subcutaneous panniculitis-like T-cell lymphoma	0.001	0.998	0.000
C86.2 Enteropathy-type (intestinal) T-cell lymphoma	0.001	0.998	0.000
C86.1 Hepatosplenic T-cell lymphoma	0.001	0.998	0.000
C86.0 Extranodal NK/T-cell lymphoma, nasal type	0.001	0.998	0.000
L30.3 Infective dermatitis	0.001	0.998	0.000
Y44.9 Other and unspecified agents affecting blood constituents	0.001	0.998	0.000
Y44.7 Plasma substitutes	0.001	0.998	0.000
Y44.6 Natural blood and blood products	0.001	0.998	0.000
Y44.1 Vitamin B12, folic acid and other anti-megaloblastic-anaemia preparations	0.001	0.998	0.000
Y50.9 Central nervous system stimulant, unspecified	0.001	0.998	0.000
Y50.8 Other central nervous system stimulants	0.001	0.998	0.000
Y50.2 Methylxanthines, not elsewhere classified	0.001	0.998	0.000
Y50.1 Opioid receptor antagonists	0.001	0.998	0.000
Y50.0 Analeptics	0.001	0.998	0.000
Y53.9 Agent primarily affecting the gastro-intestinal system, unspecified	0.001	0.998	0.000
Y53.7 Emetics	0.001	0.998	0.000
Y53.6 Antidiarrhoeal drugs	0.001	0.998	0.000
Y53.5 Digestants	0.001	0.998	0.000
Y53.3 Saline and osmotic laxatives	0.001	0.998	0.000
Y53.2 Stimulant laxatives	0.001	0.998	0.000
Y53.0 Histamine H2-receptor antagonists	0.001	0.998	0.000
G41 Status epilepticus	0.001	0.998	0.000
Q62 Congenital obstructive defects of renal pelvis and congenital malformations of ureter	0.000	0.998	0.001
M10.96 Gout, unspecified (Lower leg)	0.000	0.998	0.002
C90.1 Plasma cell leukaemia	0.001	0.998	0.000
C95.9 Leukaemia, unspecified	0.001	0.998	0.000
E61.1 Iron deficiency	0.000	0.998	0.002
F23.9 Acute and transient psychotic disorder, unspecified	0.001	0.998	0.000
G24.5 Blepharospasm	0.001	0.998	0.000
G44.1 Vascular headache, not elsewhere classified	0.001	0.998	0.000
Y53.1 Other antacids and anti-gastric-secretion drugs	0.001	0.998	0.000
M70.46 Prepatellar bursitis-Lower Leg	0.001	0.998	0.000
C95.7 Other leukaemia of unspecified cell type	0.001	0.998	0.000
C95.2 Subacute leukaemia of unspecified cell type	0.001	0.998	0.000
C95.1 Chronic leukaemia of unspecified cell type	0.001	0.998	0.000
C95.0 Acute leukaemia of unspecified cell type	0.001	0.998	0.000
G44.8 Other specified headache syndromes	0.001	0.998	0.000
J10.1 Influenza with other respiratory manifestations, influenza virus identified	0.001	0.998	0.000
M05.9 Seropositive rheumatoid arthritis, unspecified	0.001	0.998	0.000
M17.0 Primary gonarthrosis, bilateral	0.000	0.998	0.002
S05.0 Injury of conjunctiva and corneal abrasion without mention of foreign body	0.001	0.998	0.000
Y55.7 Other and unspecified agents primarily acting on the respiratory system	0.001	0.998	0.000
Y55.5 Anticommon cold drugs	0.001	0.998	0.000
Y55.4 Expectorants	0.001	0.998	0.000
Y55.3 Antitussives	0.001	0.998	0.000
Y55.2 Other and unspecified agents primarily acting on muscles	0.001	0.998	0.000
Y55.1 Skeletal muscle relaxants [neuromuscular blocking agents]	0.001	0.998	0.000
Y55.0 Oxytocic drugs	0.001	0.998	0.000
R85 Abnormal findings in specimens from digestive organs and abdominal cavity	0.000	0.998	0.002
S42 Fracture of shoulder and upper arm	0.000	0.998	0.001
C94.7 Other specified leukaemias	0.001	0.998	0.000
C94.6 Myelodysplastic and myeloproliferative disease, not elsewhere classified	0.001	0.998	0.000
C94.5 Acute myelofibrosis	0.001	0.998	0.000
C94.4 Acute panmyelosis	0.001	0.998	0.000

This table lists the top 500 terms ordered by p(effect).

The full results table can be downloaded from this page.

The TreeWAS Database is the result of research conducted at the Oxford Big Data Institute at the University of Oxford.

This research has been conducted using the UK Biobank Resource (application number 10625). This work uses data provided by patients and collected by the NHS as part of their care and support.

This research has been conducted with the support of the Wellcome Trust (100956/Z/13/Z and 090532/Z/09/Z and 100308/Z/12/Z), the Danish National Research Foundation, Takeda, the Medical Research Council (MC_UU_12010/3), the Oak Foundation (OCAY-15-520), the National Institute for Health Research (NIHR) Oxford Biomedical Research Centre (BRC), the Wellcome Trust/Royal Society (204290/Z/16/Z) and the Li Ka Shing Foundation.

Variant-specific associations